Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

InvVax

InvVax?uq=w9if130k
2012 FOUNDED
PRIVATE STATUS
1-10 EMPLOYEES
Accelerator/Inc LATEST DEAL TYPE
4 INVESTORS
Description

Developer of influenza vaccine. The company develops a universal influenza vaccine targeted at preventing virus mutations.

Website
Ownership Status
Privately Held (backing)
Financing Status
Accelerator/Incubator Backed
Primary Industry
Pharmaceuticals
Primary Office
  • 570 Westwood Plaza
  • Building 114
  • Los Angeles, CA 90095
  • United States

+1 (310) 000-0000
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore InvVax’s full profile, request a free trial.

InvVax Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Accelerator/Incubator 00000 Completed Startup
1. Seed Round 01-May-2015 00000 00000 Completed Startup
To view this company’s complete deal history including valuation and funding, request access »

InvVax Investors (4)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
Crescent Ridge Partners Ventures Venture Capital Minority 000 0000 000000 0
Life Science Angels Angel Group Minority 000 0000 000000 0
Tech Coast Angels Angel Group Minority 000 0000 000000 0
UCLA CNSI Incubator Accelerator/Incubator 000 0000 000000 0

InvVax Executive Team (3)

Name Title Board
Seat
Contact
Info
Arthur Young Ph.D President
Chris Melançon Chief Executive Officer
Matt Richter-Sand Co-Founder & Board Member

InvVax Board Members (1)

Name Representing Role Since Contact
Info
Matt Richter-Sand Self Co-Founder & Board Member 000 0000